RMS Competitor Seeks Injunction After Warning Letter

Repro-Med Systems is facing a request for injunction that would block three of the company’s products from the California market. The request was filed by competitor EMED Technologies, which alleges that RMS products are unsafe and that the company is marketing them via false and misleading statements.

A competitor of infusion pump company Repro-Med Systems Inc. (RMS) has filed for an injunction to stop RMS from selling some products in California alleging that a recent FDA warning letter against RMS shows that the company’s products are not safe for use.

EMED Technologies Corp. filed the motion for preliminary injunction on March 24 in a Sacramento, Calif., US District Court. In...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Legal & IP

More from Policy & Regulation